PBM

Propel Bio Management Portfolio holdings

AUM $82.4M
1-Year Est. Return 29.33%
This Quarter Est. Return
1 Year Est. Return
+29.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$82.4M
AUM Growth
-$3.68M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
20
New
Increased
Reduced
Closed

Top Buys

1
+$8.36M
2
+$1.99M
3
+$695K
4
MIST icon
Milestone Pharmaceuticals
MIST
+$660K
5
DCTH icon
Delcath Systems
DCTH
+$659K

Top Sells

1
+$9.95M
2
+$5.27M
3
+$2.25M
4
PHAT icon
Phathom Pharmaceuticals
PHAT
+$2.03M
5
CMPX icon
Compass Therapeutics
CMPX
+$434K

Sector Composition

1 Healthcare 69.43%
2 Energy 30.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAGP icon
1
Plains GP Holdings
PAGP
$3.35B
$24.7M 30.01%
1,272,360
ACHV icon
2
Achieve Life Sciences
ACHV
$157M
$13.9M 16.88%
6,153,091
+3,699,999
AKRO icon
3
Akero Therapeutics
AKRO
$4.3B
$12.2M 14.82%
228,884
PHAT icon
4
Phathom Pharmaceuticals
PHAT
$944M
$8.85M 10.74%
922,927
-212,000
ABEO icon
5
Abeona Therapeutics
ABEO
$280M
$5.53M 6.71%
974,022
+350,000
APLT icon
6
Applied Therapeutics
APLT
$180M
$3.51M 4.26%
11,285,420
MIST icon
7
Milestone Pharmaceuticals
MIST
$167M
$3.48M 4.22%
1,791,557
+340,000
DCTH icon
8
Delcath Systems
DCTH
$432M
$3.07M 3.73%
226,052
+48,452
TCRX icon
9
TScan Therapeutics
TCRX
$141M
$3.03M 3.67%
2,087,139
ZVRA icon
10
Zevra Therapeutics
ZVRA
$639M
$2.04M 2.48%
231,874
+52,000
CAPR icon
11
Capricor Therapeutics
CAPR
$282M
$695K 0.84%
+70,000
ATHA icon
12
Athira Pharma
ATHA
$14.4M
$451K 0.55%
1,492,792
EIGR
13
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$423K 0.51%
146,381
CMPX icon
14
Compass Therapeutics
CMPX
$776M
– –
-228,317
MDGL icon
15
Madrigal Pharmaceuticals
MDGL
$9.85B
– –
-30,032
RNA icon
16
Avidity Biosciences
RNA
$7.12B
– –
-178,500
SNDX icon
17
Syndax Pharmaceuticals
SNDX
$1.3B
– –
-183,259